This security has been delisted

Please enable Javascript and disable ad blockers

Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Search results

Bayer AG

WKN: BAY001 / Symbol: BAYZF / Name: Bayer / Stock / Pharmaceuticals / Large Cap /

BAYER AG

WKN: A255C9 / Name: BAYER / Stock / ? /

BAYER AG

WKN: A289QF / Name: BAYER / Stock / ? /

BAYER AG

WKN: A289QG / Name: BAYER / Stock / ? /

BAYER AG

WKN: A289QH / Name: BAYER / Stock / ? /

BAYER AG

WKN: A3H3EV / Name: BAYER / Stock / ? /

BAYER AG

WKN: A3H3EW / Name: BAYER / Stock / ? /

BAYER AG

WKN: A3H3EX / Name: BAYER / Stock / ? /

BAYER AG

WKN: A3MQSV / Name: BAYER / Stock / ? /

BAYER AG

WKN: A3MQSW / Name: BAYER / Stock / ? /

BAYER AG

WKN: A351U0 / Name: BAYER / Stock / ? /

BAYER AG

WKN: A351UZ / Name: BAYER / Stock / ? /

BAYER AG

WKN: A351U1 / Name: BAYER / Stock / ? /

BAYER AG

WKN: A3514W / Name: BAYER / Stock / ? /

BAYER AG

WKN: A383Q8 / Name: BAYER / Stock / ? /

BAYER AG

WKN: A4DFV1 / Name: BAYER / Stock / ? /

Bayer AG ADR

WKN: 879501 / Symbol: BAYRY / Name: Bayer / Stock / Pharmaceuticals / Large Cap /

Bayer Aktie: Brasilien-Klage zielt auf Glyphosat-Verbot

Bayer Aktie: Brasilien-Klage zielt auf Glyphosat-Verbot

Bayer geht mit einer alten Belastung in die neue Woche, nur kommt der Impuls…

Der Beitrag Bayer Aktie: Brasilien-Klage zielt auf Glyphosat-Verbot erschien zuerst auf kapitalmarktexperten.de.

Quelle

0

BAYRY's Kerendia Label Expansion Application Gets Priority Review

BAYRY's Kerendia Label Expansion Application Gets Priority Review

Bayer AG BAYRY announced that the FDA has accepted the company’s supplemental new drug application (sNDA) seeking label expansion of Kerendia (finerenone) for the treatment of chronic kidney disease

0

Baader Bank AG

WKN: 508810 / Name: Baader Bank / Stock / Investment Banking & Investment Services / Small Cap /